The Board of Karo Pharma Aktiebolag (publ) has appointed Christoffer Lorenzen as the new CEO of Karo Pharma, replacing Peter Blom. Christoffer will take on his new position on July 1, 2019. Up until this date, and effective April 3, 2019, Ulf Mattsson assumes the CEO position on an interim basis. In relation to the new ownership structure of Karo Pharma, Peter Blom initiated discussions with the Board of Directors to resign from his position as CEO. Christoffer Lorenzen, born 1975, is currently an Executive Vice President and member of the Executive Board of Chr. Hansen Holding A/S, which is listed on the Copenhagen Stock Exchange. He has previously been Head of Corporate Strategy at H. Lundbeck A/S. In February this year, he was elected as a board member of Karo Pharma, a position he will step down from in connection with Karo Pharma's next Annual General Meeting.